Kasner Mario, Sinning David, Burkhoff Daniel, Tschöpe Carsten
Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
Division of Cardiology, Columbia University, New York, USA.
Clin Res Cardiol. 2015 Nov;104(11):955-63. doi: 10.1007/s00392-015-0863-y. Epub 2015 May 9.
End-diastolic pressure-volume relationship and LV stiffness, key parameter for diagnosing diastolic dysfunction within Heart failure with preserved ejection fraction (HFpEF) patients, can be directly obtained only by invasive pressure-volume (PV) measurements. Therefore, we aimed to establish diastolic pressure-volume quotient (DPVQ), as a new non-invasive parameter for estimation of LV stiffness in HFpEF obtained by 3D echocardiography (3DE) and tissue Doppler imaging.
Twenty-three HFpEF patients with suspected diastolic dysfunction, scheduled for invasive pressure-volume loop analyses obtained by conductance catheterization were included. PV loop measurements were compared with simultaneous 3DE full-volume recordings of the LV and tissue Doppler measurements for LV diastolic function. LV filling index E/E' was used for estimation of diastolic pressure. Single-beat method was performed to calculate LV stiffness constant (β SB).
Fourteen of twenty-three patients showed increased and 9/23 revealed normal LV stiffness β. End-diastolic, end-systolic and stroke volume obtained by 3DE correlated with those from PV loop analysis (r = 0.63, r = 0.57 and r = 0.71, respectively). Estimated diastolic pressure and DPVQ correlated with invasive measurements (r = 0.81 and r = 0.91, both p < 0.001). Accordingly, calculated stiffness constant β SB revealed a significant correlation with invasive determined stiffness coefficient β (r = 0.73, p < 0.001). DPVQ and β SB correlated with NT-proBNP plasma level (r = 0.67 and r = 0.58, both, p < 0.001).
3D echocardiography allows accurate non-invasive measurements of diastolic pressure-volume quotient which correlates with invasive determined LV stiffness in HFpEF.
舒张末期压力-容积关系和左心室僵硬度是射血分数保留的心力衰竭(HFpEF)患者舒张功能障碍诊断的关键参数,目前仅能通过有创压力-容积(PV)测量直接获得。因此,我们旨在建立舒张压力-容积商(DPVQ),作为一种通过三维超声心动图(3DE)和组织多普勒成像获得的用于评估HFpEF患者左心室僵硬度的新的无创参数。
纳入23例疑似舒张功能障碍的HFpEF患者,这些患者计划通过电导导管插入术进行有创压力-容积环分析。将PV环测量结果与左心室同步3DE全容积记录和左心室舒张功能的组织多普勒测量结果进行比较。使用左心室充盈指数E/E'评估舒张压力。采用单搏法计算左心室僵硬度常数(βSB)。
23例患者中,14例左心室僵硬度β升高,9例正常。3DE获得的舒张末期、收缩末期和每搏输出量与PV环分析结果相关(r分别为0.63、0.57和0.71)。估计的舒张压力和DPVQ与有创测量结果相关(r分别为0.81和0.91,均p<0.001)。因此,计算得到的僵硬度常数βSB与有创测定的僵硬度系数β显著相关(r=0.73,p<0.001)。DPVQ和βSB与血浆N末端B型脑钠肽原(NT-proBNP)水平相关(r分别为0.67和0.58,均p<0.001)。
三维超声心动图能够准确无创测量舒张压力-容积商,该参数与HFpEF患者有创测定的左心室僵硬度相关。